Gül Dursun1, Ayşe Feyda Nursal2, Helin Deniz Demir3, Nevin Karakuş1, Osman Demir4, Serbülent Yiğit1. 1. Department of Medical Biology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey. 2. Department of Medical Genetics, Hitit University School of Medicine, Çorum, Turkey. 3. Department of Opthalmology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey. 4. Department of Biostatistics, Gaziosmanpaşa University School of Medicine, Tokat, Turkey.
Abstract
OBJECTIVE: Behçet's disease (BD), a chronic multisystem inflammatory disorder, is mainly characterized by relapsing periods of a wide range of clinical symptoms. Several cytokine genes may play important roles in the pathogenesis of BD. Therefore, interleukin-1 receptor antagonist (IL-1Ra) gene 86bp variable number tandem repeat (VNTR) variant was investigated in patients with BD in a Turkish population. METHODS: One hundred nine patients (60 females, 49 males; the mean age±standard deviation [SD] was 36.56±9.571 years) with BD and one hundred healthy individuals (54 females, 46 males; the mean age±SD was 36.64±2.294 years) were examined in the study. For genotyping, polymerase chain reaction-restriction fragment length polymorphism analysis was employed. Data were analyzed using Statistical Package for Social Sciences (SPSS) 22.0 (IBM Corp.; Armonk, NY, USA) (p<0.05). RESULTS: The genotype distribution and allele frequencies of the IL-1Ra VNTR variant did not differ significantly between the patients and the controls (p>0.05). The frequency of the a1/a1, a1/a2 genotypes and a1, a2 alleles were the most common both in patients and healthy controls (p=0.37, p=0.26, and p=0.53, respectively). Also, no statistically significant difference was found between the IL-1Ra VNTR variant genotypes and clinical characteristics (p>0.05). CONCLUSION: The results of this study do not support an association between the IL-1Ra VNTR variant and the risk of BD in a Turkish population. However, further studies of this variant with larger sample sizes and different ethnicities are required for confirmation.
OBJECTIVE: Behçet's disease (BD), a chronic multisystem inflammatory disorder, is mainly characterized by relapsing periods of a wide range of clinical symptoms. Several cytokine genes may play important roles in the pathogenesis of BD. Therefore, interleukin-1 receptor antagonist (IL-1Ra) gene 86bp variable number tandem repeat (VNTR) variant was investigated in patients with BD in a Turkish population. METHODS: One hundred nine patients (60 females, 49 males; the mean age±standard deviation [SD] was 36.56±9.571 years) with BD and one hundred healthy individuals (54 females, 46 males; the mean age±SD was 36.64±2.294 years) were examined in the study. For genotyping, polymerase chain reaction-restriction fragment length polymorphism analysis was employed. Data were analyzed using Statistical Package for Social Sciences (SPSS) 22.0 (IBM Corp.; Armonk, NY, USA) (p<0.05). RESULTS: The genotype distribution and allele frequencies of the IL-1Ra VNTR variant did not differ significantly between the patients and the controls (p>0.05). The frequency of the a1/a1, a1/a2 genotypes and a1, a2 alleles were the most common both in patients and healthy controls (p=0.37, p=0.26, and p=0.53, respectively). Also, no statistically significant difference was found between the IL-1Ra VNTR variant genotypes and clinical characteristics (p>0.05). CONCLUSION: The results of this study do not support an association between the IL-1Ra VNTR variant and the risk of BD in a Turkish population. However, further studies of this variant with larger sample sizes and different ethnicities are required for confirmation.
Entities:
Keywords:
Behçet’s disease; interleukin 1 receptor antagonist; variable number tandem repeat
Authors: J Vencovský; K Jarosová; S Růzicková; D Nemcová; J Niederlová; S Ozen; M Alikasifoglu; A Bakkaloglu; W E Ollier; R A Mageed Journal: Arthritis Rheum Date: 2001-10
Authors: A A Ozçimen; K Dilek; U Bingöl; H Sarıcaoğlu; A Sarandöl; O Taşkapılıoğlu; M Yurtkuran; M A Yurtkuran; H B Oral Journal: Int J Immunogenet Date: 2011-03-22 Impact factor: 1.466
Authors: Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis Journal: Clin Rheumatol Date: 2010-05-22 Impact factor: 2.980
Authors: J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff Journal: J Invest Dermatol Date: 1994-09 Impact factor: 8.551